![Philippe Verwaerde](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philippe Verwaerde
Director Ejecutivo en AlzProtect SAS .
Perfil
Philippe Verwaerde is the founder of Vivactis SAS, AlzProtect SAS, iNovacia AB.
He previously worked as a Principal at deVGen NV, Genfit SA, Organon SA, and Glaxo Wellcome SA.
Cargos activos de Philippe Verwaerde
Empresas | Cargo | Inicio |
---|---|---|
AlzProtect SAS
![]() AlzProtect SAS Miscellaneous Commercial ServicesCommercial Services AlzProtect SAS operates as a biotechnological company. It develops therapeutical solutions for neurodegenerative diseases. The company was founded by Andre Delacourt and Patricia Melnyk in November 2007 and is headquartered in Loos, France. | Director Ejecutivo | - |
Antiguos cargos conocidos de Philippe Verwaerde.
Empresas | Cargo | Fin |
---|---|---|
Organon SA | Corporate Officer/Principal | - |
GENFIT | Corporate Officer/Principal | - |
deVGen NV
![]() deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - |
Glaxo Wellcome SA
![]() Glaxo Wellcome SA Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Glaxo Wellcome SA is a Spanish company that manufactures and markets medicines. The company is based in Aranda de Duero, Spain. | Corporate Officer/Principal | - |
iNovacia AB
![]() iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GENFIT | Health Technology |
Empresas privadas | 6 |
---|---|
Vivactis SAS
![]() Vivactis SAS Miscellaneous Commercial ServicesCommercial Services Vivactis SAS specializes in healthcare communications and marketing services. The company is based in Neuilly-sur-Seine, France. The French company was founded by Jean-Claude Sauli, Philippe Verwaerde. Vivactis was acquired by Vivactis Group SA on February 29, 2008. | Commercial Services |
deVGen NV
![]() deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Health Technology |
AlzProtect SAS
![]() AlzProtect SAS Miscellaneous Commercial ServicesCommercial Services AlzProtect SAS operates as a biotechnological company. It develops therapeutical solutions for neurodegenerative diseases. The company was founded by Andre Delacourt and Patricia Melnyk in November 2007 and is headquartered in Loos, France. | Commercial Services |
iNovacia AB
![]() iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Commercial Services |
Organon SA | |
Glaxo Wellcome SA
![]() Glaxo Wellcome SA Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Glaxo Wellcome SA is a Spanish company that manufactures and markets medicines. The company is based in Aranda de Duero, Spain. | Health Technology |
- Bolsa de valores
- Insiders
- Philippe Verwaerde